Which peptides have been studied in bone health research?
-
Abaloparatide
Synthetic 34-amino-acid peptide modelled on PTHrP, studied for osteoporosis. UK prescription-only medicine; the main trial compared it with placebo.
StrongLicensed UK medicine -
Teriparatide
34-amino-acid fragment of parathyroid hormone, studied for osteoporosis. UK prescription-only medicine; trials looked at spine and hip fractures.
StrongLicensed UK medicine
Best recorded finding for each peptide in this area
| Peptide | UK status | Finding | Study type | Evidence grade |
|---|---|---|---|---|
| Abaloparatide | Licensed UK medicine | The ACTIVE trial | Human trial | Strong |
| Teriparatide | Licensed UK medicine | Fractures versus placebo | Human trial | Strong |
About this research area
"Bone Health Research" groups peptides studied for effects on bone formation, bone density and fracture risk, most commonly parathyroid-hormone-pathway peptides investigated in osteoporosis. Evidence in this category includes large randomised phase 3 fracture trials, active-comparator trials and long-term surveillance studies, alongside animal carcinogenicity findings that shape licensed-use warnings. Inclusion here reflects a documented line of bone-related research, not an effect for any individual.
11 sources in the library relate to this area. See them.
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.